Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Cash from Investing Activities (2016 - 2022)

Palisade Bio (PALI) has disclosed Cash from Investing Activities for 11 consecutive years, with -$10000.0 as the latest value for Q4 2022.

  • On a quarterly basis, Cash from Investing Activities changed N/A to -$10000.0 in Q4 2022 year-over-year; TTM through Sep 2024 was -$10000.0, a 9.09% increase, with the full-year FY2023 number at -$4000.0, up 60.0% from a year prior.
  • Cash from Investing Activities was -$10000.0 for Q4 2022 at Palisade Bio, down from -$1000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $5.0 million in Q1 2018 to a low of -$10000.0 in Q4 2022.
  • A 3-year average of $997657.2 and a median of -$1000.0 in 2020 define the central range for Cash from Investing Activities.
  • Biggest YoY gain for Cash from Investing Activities was 320.1% in 2018; the steepest drop was 320.1% in 2018.
  • Palisade Bio's Cash from Investing Activities stood at -$1714.0 in 2018, then soared by 41.66% to -$1000.0 in 2020, then crashed by 900.0% to -$10000.0 in 2022.
  • Per Business Quant, the three most recent readings for PALI's Cash from Investing Activities are -$10000.0 (Q4 2022), -$1000.0 (Q4 2020), and $1000.0 (Q3 2020).